Standardization and short-term outcomes of robot-assisted minimally invasive esophagectomy in the semi-prone position

Abstract

Robot-assisted minimally invasive esophagectomy (RAMIE) has recently been developed and is increasingly performed for thoracic esophageal and esophagogastric junction (EGJ) cancers. At our institute, we performed RAMIE in the semi-prone position using the da Vinci Xi system with two- or three-field lymphadenectomy in 91 patients with resectable thoracic esophageal or EGJ cancers between October 2018 and March 2023. During this period, we improved and standardized the surgical procedures to perform precise and safe mediastinal lymphadenectomies and minimize postoperative complications. The rates of major operative morbidities (C-D grade, ≥ I) were acceptable (recurrent laryngeal nerve paralysis, 6.6%; pneumonia, 9.9%; atelectasis, 6.7%; anastomotic leak, 14.3%). Both operative and 30-day mortality rates were 0%. In this technical note, we present our standardized surgical techniques for RAMIE in the semi-prone position for esophageal and EGJ cancers.

Keywords

Robot / da Vinci / esophagectomy / lymphadenectomy / esophageal cancer

References

[1] Sung H,Siegel RL.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2021;71:209-49

[2] Manabe N,Haruma K.Epidemiological review of gastroesophageal junction adenocarcinoma in Asian countries.Digestion2022;103:29-36

[3] Ozawa S,Ando T,Aoki T.Essential updates 2020/2021: recent topics in surgery and perioperative therapy for esophageal cancer.Ann Gastroenterol Surg2023;7:346-57 PMCID:PMC10154818

[4] Booka E,Kikuchi H.Recent advances in thoracoscopic esophagectomy for esophageal cancer.Asian J Endosc Surg2019;12:19-29

[5] Takeuchi H,Ozawa S.Comparison of short-term outcomes between open and minimally invasive esophagectomy for esophageal cancer using a nationwide database in Japan.Ann Surg Oncol2017;24:1821-7

[6] Booka E,Haneda R.Short-term outcomes of robot-assisted minimally invasive esophagectomy compared with thoracoscopic or transthoracic esophagectomy.Anticancer Res2021;41:4455-62

[7] Kikuchi H,Matsumoto T.The hybrid position is superior to the prone position for thoracoscopic esophagectomy with upper mediastinal lymphadenectomy.Ann Laparosc Endosc Surg2020;5:13

[8] Hosoda K,Harada H,Hiki N.Robot-assisted minimally invasive esophagectomy for esophageal cancer: meticulous surgery minimizing postoperative complications.Ann Gastroenterol Surg2020;4:608-17 PMCID:PMC7726681

[9] van der Horst S,Braunius WW.Safety and feasibility of robot-assisted minimally invasive esophagectomy (RAMIE) with three-field lymphadenectomy and neoadjuvant chemoradiotherapy in patients with resectable esophageal cancer and cervical lymph node metastasis.Ann Surg Oncol2023;30:2743-52

[10] van der Sluis PC,May AM.Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: a randomized controlled trial.Ann Surg2019;269:621-30

[11] Yang Y,Yi J.Robot-assisted versus conventional minimally invasive esophagectomy for resectable esophageal squamous cell carcinoma: early results of a multicenter randomized controlled trial: the RAMIE trial.Ann Surg2022;275:646-53

[12] Chao YK,Wen YW.Robotic-assisted esophagectomy vs video-assisted thoracoscopic esophagectomy (REVATE): study protocol for a randomized controlled trial.Trials2019;20:346 PMCID:PMC6558787

[13] Haneda R,Nagakura Y.Development and validation of the optimal circumferential resection margin in pathological T3 esophageal cancer: a multicenter, retrospective study.Ann Surg Oncol2022;29:4452-61

[14] Okada N,Fujita T.The prognostic significance of the positive circumferential resection margin in pathologic T3 squamous cell carcinoma of the esophagus with or without neoadjuvant chemotherapy.Surgery2016;159:441-50

[15] Evans R,Kaur P,Griffiths EA.Meta-analysis of the influence of a positive circumferential resection margin in oesophageal cancer.BJS Open2019;3:595-605 PMCID:PMC6773635

[16] Kikuchi H.Future perspectives of surgery for esophageal cancer.Ann Thorac Cardiovasc Surg2018;24:219-22 PMCID:PMC6197999